Perioral dermatitis
Periorificial dermatitis Β· steroid-induced rosacea-like dermatitis
Perioral dermatitis is a chronic eruption of small grouped erythematous papules and pustules around the mouth β sparing the vermilion border β that may extend to the perinasal and periocular regions (perioral / periorificial dermatitis). Classically affects young women but also occurs in children. Topical corticosteroids and fluorinated dental products are the most important triggers. It is a very common rosacea-mimic and important steroid-related complication in patients who have received facial corticosteroids for unrelated skin oncology indications (e.g. post-Mohs scars, BAD-managed eczema).
Triggers and pathogenesis
- Topical / inhaled corticosteroids (commonest trigger) β onset typically weeks to months after starting; flares on withdrawal.
- Heavy occlusive moisturisers, sunscreens, cosmetics.
- Fluorinated toothpaste, mouthwash.
- Oral contraceptives, hormonal fluctuation (pregnancy, menstrual).
- Demodex folliculorum / candida overgrowth implicated in some cases.
- Female young adults predominant; paediatric variant also recognised.
Clinical features
- Small (1-2 mm) erythematous papules / pustules / fine scaly plaques.
- Symmetric distribution around the mouth.
- Characteristic sparing of the vermilion border (clear margin 3-5 mm wide).
- Periocular and perinasal extension common ("periorificial dermatitis").
- Mild pruritus, burning; cosmetic distress prominent.
- Course: months; recurrent if steroid trigger continued.
- Granulomatous variant (more common in children, particularly skin of colour): flesh-coloured / red-brown discrete papules.
Differentials
- Acne vulgaris β comedones present; broader distribution.
- Rosacea β central face, telangiectasia, vermilion not specifically spared.
- Contact dermatitis β pruritus dominates; geometric.
- Seborrhoeic dermatitis β greasy scale, nasolabial.
- Demodex folliculitis.
- Lupus malar rash.
Management
- Stop the trigger:
- Discontinue topical / inhaled corticosteroids (counsel about expected flare); switch inhaled steroids to spacer; change toothpaste to non-fluorinated.
- Stop occlusive cosmetics and moisturisers.
- Bland skincare: gentle non-soap cleanser; bland emollient if needed.
- Topical first-line: metronidazole 0.75% gel/cream BD, azelaic acid 15-20%, ivermectin 1%, erythromycin 2%, pimecrolimus 1%.
- Oral: tetracyclines (lymecycline, doxycycline, oxytetracycline) for 6-12 weeks if topical inadequate.
- Paediatric: oral erythromycin / clarithromycin (tetracyclines contraindicated <8 years).
- Counsel about delay before resolution (2-3 months); pre-warn of initial rebound.
References
- Tempark T, Shwayder TA. Perioral dermatitis: a review of the condition with special attention to treatment options. Am J Clin Dermatol. 2014;15:101-113.
- Hafeez ZH. Perioral dermatitis: an update. Int J Dermatol. 2003;42:514-517.
- Tolaymat L, Hall MR. Perioral dermatitis. StatPearls. Treasure Island: StatPearls Publishing; 2023.
- British Association of Dermatologists. Periorificial dermatitis β patient information leaflet. London: BAD; 2022.
Spot a correction?
If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.

